Výsledky vyhledávání

Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction - Baseline Characteristics and Treatment of PARALLEL-HF Trial

Autor: Naoko Okino, Weinong Guo, Shin Ichi Momomura, Kazuhiro Yamamoto, Yoshihiko Saito, Hiroshi Ito, Hiroyuki Tsutsui, Toshihito Kitamura, Tomomi Ohishi

Publikováno v: Circulation journal : official journal of the Japanese Circulation Society. 82(10)

Background The objective of the present analyses was to describe the baseline characteristics and treatment of the Japanese patients with HFrEF in THE PARALLEL-HF study. Methods and Results: Key demographic, clinical and laboratory findings, along wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a5e5d3dea2f52658a9c3fc0949690ad
https://pubmed.ncbi.nlm.nih.gov/30210071

Zobrazit plný text záznamu

Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study

Autor: Hiroshi Ito, Naoko Okino, Weinong Guo, Shin-ichi Momomura, Yoshihiko Saito, Kazuhiro Yamamoto, Hiroyuki Tsutsui, Tomomi Ohishi

Publikováno v: Journal of Cardiology.

Background The prognosis of heart failure patients with reduced ejection fraction (HFrEF) in Japan remains poor, although there is growing evidence for increasing use of evidence-based pharmacotherapies in Japanese real-world HF registries. Sacubitri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8677f6aabf33d07d53264249d22d4901

Zobrazit plný text záznamu

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12-week, placebo-controlled study

Autor: Naoko Okino, Masakazu Ichinose, Yoshinosuke Fukuchi, Benjamin Kramer, Motoi Hosoe, Niyati Prasad, Masaharu Kinoshita, Sang Haak Lee, Liang Wen Hang

Publikováno v: Respirology. 17:379-389

Background and objective: The efficacy and safety of indacaterol, a novel inhaled once daily ultra long-acting β2-agonist was evaluated in COPD patients in six Asian countries/areas. This study was primarily designed to obtain the regulatory approva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10b9fc25a27d04e5b99f8d7528ae9bd5
https://doi.org/10.1111/j.1440-1843.2011.02107.x

Zobrazit plný text záznamu

LCZ696, a First‐in‐Class Angiotensin Receptor‐Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension

Autor: Yuko Tamaki, Jack Zhang, Min Zhu, Naoko Okino, Kazuomi Kario, Hiromi Gotou

Publikováno v: J Clin Hypertens (Greenwich)

The safety of LCZ696, a novel angiotensin receptor-neprilysin inhibitor, was evaluated for the first time in patients with severe hypertension in this 8-week, multicenter, open-label study. Thirty-five Japanese patients with either office systolic bl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a050662efde797408044af6e99e54d3e
https://europepmc.org/articles/PMC8032009/

Zobrazit plný text záznamu

Abstract 474: Efficacy and Safety of LCZ696 Compared with Olmesartan in Japanese Patients with Systolic Hypertension

Autor: Jack Zhang, Hiromi Rakugi, Masako Yamaguchi, Naoko Okino, Kazuomi Kario, Hiromi Gotou

Publikováno v: Hypertension. 64

Objective: To evaluate the efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor (ARNI) vs olmesartan in Japanese patients with systolic hypertension (SH). Methods: Patients aged ≥20 yrs with mean sitting (ms) SB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c825078453e6552a098d34daa1e7ffc
https://doi.org/10.1161/hyp.64.suppl_1.474

Zobrazit plný text záznamu

Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction

Autor: Sadayoshi Ito, Mizuki Akahori, Hiromi Gotou, Alan Charney, Yuko Tamaki, Jack Zhang, Naoko Okino, Minoru Satoh

Publikováno v: Hypertension Research

This 8-week, multi-center, open-label study assessed the safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Patients (n=32) with mean sitting systol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b485511e67df49aeaf6f5d4a5fef943
https://pubmed.ncbi.nlm.nih.gov/25693859

Zobrazit plný text záznamu

Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population

Autor: Yasuo To, Liang Wen Hang, Masaharu Kinoshita, Tetsuji Kitawaki, Yoshinosuke Fukuchi, Niyati Prasad, Masakazu Ichinose, Naoko Okino, Benjamin Kramer, David Lawrence, Sang Haak Lee

Publikováno v: Respiratory medicine. 106(12)

SummaryIntroductionThis post hoc analysis evaluated the efficacy of indacaterol, a novel inhaled once-daily long-acting β2-agonist, by disease severity (GOLD 2005) in patients with moderate-to-severe COPD from six Asian countries/areas (Hong Kong, I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe1ed0e82626f8786fc7917bef3af72
https://pubmed.ncbi.nlm.nih.gov/23040786

Zobrazit plný text záznamu

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study

Autor: Masaharu, Kinoshita, Sang Haak, Lee, Liang-Wen, Hang, Masakazu, Ichinose, Motoi, Hosoe, Naoko, Okino, Niyati, Prasad, Benjamin, Kramer, Yoshinosuke, Fukuchi

Publikováno v: Respirology (Carlton, Vic.). 17(2)

The efficacy and safety of indacaterol, a novel inhaled once daily ultra long-acting β(2) -agonist was evaluated in COPD patients in six Asian countries/areas. This study was primarily designed to obtain the regulatory approval of indacaterol in Jap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ee9459fbd484c70e1aeb072de57bd976
https://pubmed.ncbi.nlm.nih.gov/22122202

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání